Senior Identity Protection Specialist

FUJIFILM India deepens its commitment for advance semiconductor materials manufacturing, signs an MoU with the Government of Gujarat. FUJIFILM India has signed a Memorandum of Understanding (MoU) with the Gujarat State Electronics Mission (GSEM), Department of Science and Technology (DST), Government of Gujarat, at the Vibrant Gujarat Regional Conference in Vadodara to explore opportunities for manufacturing semiconductor materials in the country and strengthening domestic supply chain capabilities. The collaboration aligns with India's vision of becoming a global semiconductor hub and underscores FUJIFILM India's intent to play a meaningful role in advancing the nation's technology and manufacturing landscape. Through the MoU, FUJIFILM India aims to assess opportunities to establish a semiconductor materials production base in Dholera while working closely with government stakeholders, industry bodies, and private enterprises to support the development of a robust and resilient semiconductor supply chain. As demand for semiconductors continues to grow across sectors including electronics, automotive, telecommunications, and artificial intelligence, the initiative is expected to contribute to enhancing India's self-reliance in critical semiconductor materials and strengthening the country's position within the global value chain. Commenting on the occasion, Mr. Koji Wada, Managing Director, FUJIFILM India said, "At FUJIFILM India, we have been closely assessing opportunities across the Indian market and evaluating how our diverse businesses can contribute to the country's long-term growth and innovation ambitions. This MoU marks an important milestone in that journey and brings us a step closer to realizing our plans for investment in Dholera. Guided by our Group Purpose of 'Giving our world more smiles,' we believe innovation should create meaningful value for society. By supporting the development of critical technologies and manufacturing capabilities in India, we hope to contribute to economic growth and technological advancement of the nation." Mr. Abhi Shekhar Singh, National Head - Strategy & Business Development, Electronic Materials Division, FUJIFILM India added, "FUJIFILM Electronic Materials develops and manages chemical formulations that power the most critical processes of semiconductor technology. We are a diverse, global supplier that delivers tailored support where our customers need us most. The spirit of partnership drives everything we do, our commitment to the continued success and innovation of our customers is our primary focus. Globally, Fujifilm recognizes its vital role in supporting and advancing many of the changes we see in our everyday lives and now we are gearing up to introduce our technology to the semiconductor ecosystem in India which will support Today's aspirational India which will guarantee of tomorrow's Viksit Bharat." With more than 20 production bases worldwide and extensive expertise in advanced materials, Fujifilm Electronic Materials views India as a strategic market for future growth and innovation. The MoU reflects the broader vision of supporting the Government of India's "Make in India" initiative through localized manufacturing, technology collaboration, and supply chain development. By deepening its engagement with India's semiconductor ecosystem, Fujifilm aims to contribute to the creation of a sustainable, future-ready manufacturing infrastructure that supports the country's long-term ambitions in the semiconductor sector. If you have an interesting Article / Report/case study to share, please get in touch with HYB Group at [email protected], [email protected], 9811346846/ 9625243429 IMAGING SOLUTION Bureau: If you have an interesting article/experience/case study related to the ICT industry to share, please send HYB Group at [email protected]

Global biopharmaceutical FDI surges with multi-billion dollar investments in Germany, Singapore, and the US. June 30, 2026 The global biopharmaceutical sector is experiencing a significant wave of foreign direct investment (FDI), as leading multinational corporations expand their manufacturing footprints across Europe, Asia, and North America. These strategic capital deployments aim to secure production capacity for advanced therapeutics, including targeted cancer treatments and next-generation diabetes and obesity medications. In Europe, U.S. pharmaceutical giant Eli Lilly recently broke ground on its new €2.3 billion ($2.5 billion) high-tech manufacturing facility in Alzey, Germany. According to reports from Reuters, Bloomberg, and the Financial Times, the site will focus on producing the company's highly sought-after diabetes and obesity treatments, alongside injectable delivery devices. The project represents a major FDI injection into Germany's pharmaceutical ecosystem and is projected to create more than 1,000 highly skilled jobs when it becomes operational in 2027. This development highlights Germany's ongoing appeal for high-tech healthcare investments despite broader regional economic shifts. Simultaneously, Southeast Asia is cementing its status as a premier biomedical hub. Anglo-Swedish drugmaker AstraZeneca announced plans to invest $1.5 billion to construct an advanced manufacturing facility in Singapore. As reported by Reuters, Bloomberg, and The Straits Times, this facility will specialize in manufacturing antibody-drug conjugates (ADCs), which are highly targeted cancer therapies. The plant is expected to begin operations by 2029, representing a high-value expansion of AstraZeneca's global production network and reflecting Singapore's competitive advantages in attracting sophisticated biomedical manufacturing. Meanwhile, Japanese conglomerate Fujifilm Corporation is deepening its commitment to the North American market. Reuters, Bloomberg, and BioPharma Reporter indicate that Fujifilm will invest an additional $1.2 billion to expand its cell culture biopharmaceutical contract development and manufacturing organization (CDMO) facility in Clayton, North Carolina. This new capital injection raises Fujifilm's total planned investment at the Clayton site to over $3.2 billion. The expansion will add large-scale bioreactors and generate hundreds of high-skilled jobs, highlighting sustained Japanese FDI in the U.S. healthcare and biotechnology sectors. These coordinated global investments reflect a broader trend of pharmaceutical companies establishing localized, high-tech manufacturing facilities to meet rising global demand. By diversifying production across key regions, these corporations are building more resilient supply chains capable of delivering critical medical treatments to global markets while fostering high-skilled employment opportunities in host nations. #BiopharmaFDI #HealthcareInvestment #GlobalTrade #Biotech The International Trade Council is a global, peak-body, chamber of commerce that supports businesses and governments by providing resources, advocacy, and networking opportunities to promote international trade and foreign direct investment. It serves as a platform for organizations to collaborate, share knowledge, and navigate the complexities of global markets. About. Resources. Legal. (C) 2026 - International Trade Council. A Peak-Body, Chamber of Commerce. NOT affiliated with the ICC or Intracen.

Fujifilm, Tokyo Gas and TGES agree to supply city gas linked to biomethane produced overseas. TOKYO, June 25, 2026 - FUJIFILM Corporation, Tokyo Gas Co., Ltd. and Tokyo Gas Engineering Solutions Corporation have reached an agreement for the supply of city gas linked to biomethane produced overseas[*1] to Fujifilm's Ashigara Site at the Kanagawa Factory. This agreement marks the first[*2] initiative in Japan's chemical industry to use such city gas at a manufacturing site. This agreement is a preliminary initiative on a pilot basis to verify the future potential of using such city gas supplied under an arrangement linked to biomethane produced overseas, while assessing regulatory treatment, supply stability, costs and other factors. The city gas supplied under this agreement will be used in part of the Ashigara Site. The three companies will continue working together on initiatives related to the decarbonization of energy use at manufacturing sites. Biomethane is produced by capturing and reusing organic methane[*3] released into the atmosphere. When used as an alternative to fossil fuels, biomethane is expected to be one option for addressing greenhouse gas emissions associated with fuel use. Since its main component is methane, the same as city gas, biomethane can be used through existing LNG and city gas infrastructure. In Japan, discussions are currently underway at government councils and other bodies regarding the requirements for the treatment of biomethane produced overseas under the SHK System[*4]. In addition, the Science Based Targets initiative (SBTi)[*5] is revising standards related to companies' net-zero targets, and the treatment of bioenergy under international standards such as the GHG Protocol is also being discussed. Comment from yasuhisa tazawa, Corporate vice president and general manager, material manufacturing headquarters, FUJIFILM Corporation. FUJIFILM Holdings Corporation has set a goal of reducing CO[2] emissions associated with energy used in its own operations to net zero by 2040, and the Fujifilm Group is advancing initiatives toward decarbonization within its operations. In manufacturing processes, not only electricity but also thermal energy is required. To reduce greenhouse gas emissions, it is important to combine various measures, including energy conservation, the introduction of renewable electricity and a shift to lower-carbon fuels. The use of city gas supplied under an arrangement linked to biomethane produced overseas is a preliminary initiative to explore options for decarbonizing fuel use in manufacturing processes, particularly at manufacturing sites in the chemical industry. Through continued collaboration with the Tokyo Gas Group, Fujifilm Limited will steadily advance initiatives related to the decarbonization of fuel use in manufacturing processes. Comment from natsuya ozono, executive officer and general manager, industrial energy sales Division, Tokyo Gas Engineering Solutions Corporation. Tokyo Gas and TGES provide solutions in the areas of decarbonization, optimization and resilience under the solution business brand "IGNITURE"[*6], extending beyond the energy field. In the Tokyo Gas Group's FY2026-FY2028 Medium-Term Management Plan, the Group is promoting the introduction and expanded use of e-methane, biomethane and other solutions as part of its initiatives toward energy decarbonization. Tokyo Gas and TGES have built a long-standing partnership with Fujifilm, including the provision of onsite energy services for the Ashigara Site, such as the supply of utilities including electricity, water, air and other services, including on-site power generation. Fujifilm Limited is very pleased to have reached this agreement to supply city gas under an arrangement linked to biomethane produced overseas to Fujifilm as part of initiatives related to energy decarbonization. Fujifilm Limited will continue working together on initiatives related to energy decarbonization at the Fujifilm Group's manufacturing sites. * *1 Biomethane is biogas refined to increase its methane concentration to a level comparable to that of natural gas. * *2 As an initiative to supply city gas under an arrangement linked to biomethane produced overseas to manufacturing sites in the chemical industry in Japan. Based on publicly available information and research by Tokyo Gas. * *3 Methane gas generated during the decomposition of organic matter, such as food waste and livestock manure, by microorganisms. * *4 The Greenhouse Gas Emissions Accounting, Reporting and Disclosure System under the Act on Promotion of Global Warming Countermeasures. The accounting and reporting treatment of greenhouse gas emissions associated with this initiative will be determined in accordance with applicable regulatory requirements and relevant accounting methodologies as these are developed and finalized. This initiative does not, by itself, establish a specific reportable emissions reduction for the parties involved. * *5 Science Based Targets initiative, an international climate action initiative. * *6 For details on IGNITURE, please refer to the Tokyo Gas website. Related link. Contact. FUJIFILM Holdings Corporation Corporate Communications Division Public Relations Group * * Please note that the contents including the product availability, specification, prices and contacts in this website are current as of the date of the press announcement and may be subject to change without prior notice.